160 related articles for article (PubMed ID: 1279104)
1. Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein.
Sato A; Isaka Y; Morita F; Ishii A; Goto Y; Imai J; Igarashi H; Yoshie O; Hinuma Y
J Gen Virol; 1992 Nov; 73 ( Pt 11)():2969-73. PubMed ID: 1279104
[TBL] [Abstract][Full Text] [Related]
2. Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein.
Palker TJ; Singer KH; Vahlne A
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):10-9. PubMed ID: 8528727
[TBL] [Abstract][Full Text] [Related]
3. Differential antibody responsiveness to p19 gag results in serological discrimination between human T lymphotropic virus type I and type II.
Lal RB; Brodine SK; Coligan JE; Roberts CR
J Med Virol; 1991 Dec; 35(4):232-6. PubMed ID: 1687064
[TBL] [Abstract][Full Text] [Related]
4. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.
Mahieux R; Horal P; Mauclère P; Mercereau-Puijalon O; Guillotte M; Meertens L; Murphy E; Gessain A
J Clin Microbiol; 2000 Nov; 38(11):4049-57. PubMed ID: 11060067
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II.
Palker TJ; Scearce RM; Ho W; Copeland TD; Oroszlan S; Popovic M; Haynes BF
J Immunol; 1985 Jul; 135(1):247-54. PubMed ID: 2987346
[TBL] [Abstract][Full Text] [Related]
6. Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.
Hernández M; Selles ME; Pozo Peña L; Gómez I; Melchor A
Biochem Biophys Res Commun; 2000 Oct; 276(3):1085-8. PubMed ID: 11027594
[TBL] [Abstract][Full Text] [Related]
7. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
[TBL] [Abstract][Full Text] [Related]
8. Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II.
Lal RB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S170-8. PubMed ID: 8797720
[TBL] [Abstract][Full Text] [Related]
9. Production and characterization of a monoclonal antibody directed against HTLV-1 p19: use in a specific capture enzyme immunoassay.
Ebersold A; Noraz N; Grange J; Gasmi M; Grange MP; Souche S; Mamoun R; Desgranges C
Hybridoma; 1993 Apr; 12(2):185-95. PubMed ID: 7686136
[TBL] [Abstract][Full Text] [Related]
10. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
[TBL] [Abstract][Full Text] [Related]
11. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
Bonis J; Baillou A; Barin F; Verdier M; Janvier B; Denis F
J Clin Microbiol; 1993 Jun; 31(6):1481-5. PubMed ID: 8314990
[TBL] [Abstract][Full Text] [Related]
12. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
[TBL] [Abstract][Full Text] [Related]
13. The trans-activating C-type retroviruses share a distinct epitope(s) that induces antibodies in certain infected hosts.
Zandomeni RO; Carrera-Zandomeni M; Esteban E; Ferrer JF
J Gen Virol; 1991 Sep; 72 ( Pt 9)():2113-9. PubMed ID: 1716653
[TBL] [Abstract][Full Text] [Related]
14. C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.
Palker TJ; Scearce RM; Copeland TD; Oroszlan S; Haynes BF
J Immunol; 1986 Apr; 136(7):2393-7. PubMed ID: 2419433
[TBL] [Abstract][Full Text] [Related]
15. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
[TBL] [Abstract][Full Text] [Related]
16. Increased seroreactivity to human T cell lymphoma/leukemia virus-related endogenous sequence-1 Gag peptides in patients with human T cell lymphoma/leukemia virus myelopathy.
Perzova R; Graziano E; Sanghi S; Welch C; Benz P; Abbott L; Lalone D; Glaser J; Loughran T; Sheremata W; Poiesz BJ
AIDS Res Hum Retroviruses; 2015 Feb; 31(2):242-9. PubMed ID: 25295378
[TBL] [Abstract][Full Text] [Related]
17. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease.
Brookes SM; Pandolfino YA; Mitchell TJ; Venables PJ; Shattles WG; Clark DA; Entwistle A; Maini RN
Br J Rheumatol; 1992 Nov; 31(11):735-42. PubMed ID: 1280512
[TBL] [Abstract][Full Text] [Related]
18. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies.
Banki K; Maceda J; Hurley E; Ablonczy E; Mattson DH; Szegedy L; Hung C; Perl A
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1939-43. PubMed ID: 1347429
[TBL] [Abstract][Full Text] [Related]
19. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.
Oroszlan S; Copeland TD; Rice NR; Smythers GW; Tsai WP; Yoshinaka Y; Shimotohno K
Princess Takamatsu Symp; 1984; 15():147-57. PubMed ID: 6100635
[TBL] [Abstract][Full Text] [Related]
20. Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.
Noraz N; Benichou S; Madaule P; Tiollais P; Vernant JC; Desgranges C
Virology; 1993 Mar; 193(1):80-8. PubMed ID: 7679862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
